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LEPTOSPIROSIS SEVERITY MAY BE ASSOCIATED WITH THE INTENSITY OF
HUMORAL IMMUNE RESPONSE
Regina C.R.M. ABDULKADER(1), Elizabeth F. DAHER(2), Eide D. CAMARGO(3), Cláudia SPINOSA(3) & Marcos Vinícius da SILVA(4)
SUMMARY
Leptospirosis severity may be increasing, with pulmonary involvement becoming more frequent. Does this increase result from
an intense immune response to leptospire? Notice that renal failure, thrombocytopenia and pulmonary complications are found
during the immune phase. Thirty-five hospitalized patients with Weil’s disease had 5 blood samples drawn, from the 15th day to the
12th month of symptoms, for ELISA-IgM, -IgG and -IgA specific antibody detection. According their 1st IgG titer, the patients were
divided into: group 1 (n = 13) titer > 1:400 (positive) and group 2 (n = 22) titer 1:400 (negative). Early IgG antibodies in group 1
showed high avidity which may indicate reinfection. Group 1 was older, had worse pulmonary and renal function, and fever for a
longer period than group 2. Throughout the study, IgG and IgA titers remained higher in group 1. In conclusion, the severity of Weil’s
disease may be associated with the intensity of the humoral immune response to leptospire.
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INTRODUCTION
In Brazil, it seems that clinical patterns of Weil’s disease have
changed; more severe cases are now being detected - mainly with
pulmonary involvement5,16. In India, the same observation was reported
by SINGH et al.20. Their study suggests that the pulmonary complications
of leptospirosis may have a pathogenesis different from other
complications. In a previous retrospective study analyzing 110 patients
with Weil’s disease hospitalized from 1985 to 1996, we showed that in
the 1995-1996 period the frequency of arthralgia, dyspnea, pulmonary
rales and dehydration was higher than in the 1985-1993 period5. We
suggested that those changes could result from an intense immune
response consequent to previous leptospira infection as it occurs in dengue
hemorrhagic fever11.
It is well known that, in leptospirosis, the signs and symptoms of
renal and hepatic involvement appear in the immune phase when specific
agglutinins begin to be detected10. Thrombocytopenia present in this
phase has been attributed to immune mechanisms6. Could those patients
with more intense humoral response have a more severe form of the
disease?
PATIENTS AND METHODS
Patients: Thirty-five patients admitted at Walter Cantídio Universitary
Hospital in Fortaleza, CE, from May 1996 to June 1998 with a confirmed
diagnosis of leptospirosis were prospectively studied. Leptospirosis
diagnosis was suspected by epidemiological and clinical data and
confirmed by the presence of specific IgM titer > 1:400 in a blood sample
collected at about the 15th day after the onset of symptoms. All patients
had jaundice and acute renal failure. Acute renal failure was defined as
at least one plasma creatinine (P
creat
) value > 1.5 mg/dL during
hospitalization. The patients were evaluated at hospital admission,
throughout the hospitalization and at hospital discharge. The evaluated
parameters were: time (S) from the onset of symptoms to hospital
admission, time (H) of hospitalization, time (F) of fever (axilar
temperature  37.5 °C), time (O) of oliguria (urinary volume  600
mL/24 hours after hydration), time (P
creat
) to normalize P
creat
 (<1.5 mg/
dL), time (Plat) to normalize platelets ( 150,000/mm3) and time (B)
for total bilirubin value to reach 1/3 of its maximum value or to normalize
( 0.8 mg/dL). At admission, the following signs and symptoms were
also recorded: myalgia, jaundice, dehydration, vomiting, cephalea,
arthralgia, hepatomegalia, dyspnea, bloody sputum, cardiac arrhythmia
and convulsion. The evaluated laboratory parameters were: (maximum
values) leukocytes, bilirubin, hepatic enzymes, creatinekinase, lactic
dehydrogenase, P
creat
 and proteinuria; (minimum values) hemoglobin,
platelets, albumin, arterial partial oxygen pressure while breathing room
air, arterial bicarbonate, and plasma sodium and potassium. Also, the
need for dialysis and penicillin administration was recorded. Penicillin
(6,000,000 units/day for 8 days) was prescribed by the assistant
infectologist. There is no consensus among the infectious diseases
specialists of Walter Cantídio Hospital, or even among the present
@
ABDULKADER, R.C.R.M.; DAHER, E.F.; CAMARGO, E.D.; SPINOSA, C. & SILVA, M.V. - Leptospirosis severity may be associated with the intensity of humoral immune response. Rev.
Inst. Med. trop. S. Paulo, 44(2):79-83, 2002.
authors, on the treatment with penicillin: some of them always treat,
others never treat and none of them take into account any clinical or
laboratory parameter. The patients were divided into 2 groups according
to the first IgG titer: group 1 (n = 13) those with IgG titer > 1:400 and
group 2 (n = 22) those with IgG titer  1:400, i. e., negative.
Serological studies: Blood samples were drawn for the serological
studies and grouped, according to the onset of symptoms, into: 1st sample
(n = 35) drawn 15 ± 3 days from the onset of symptoms, 2nd sample (n =
26) 30 ± 2 days, 3rd sample (n = 26) 4 ± 1 months, 4th sample (n = 21) 6
± 1 months, 5th sample (n = 14) 9 ± 1 months and 6th sample (n = 15) 12
± 1 months. At least 2 samples were drawn from thirty-two patients and
five of those had all 6 samples drawn. Three patients had only the first
sample drawn. Of those three, one died during hospitalization and the
other two withdrew from the study prior to the drawing of the 2nd sample.
A control negative group, for specific ELISA-IgM, -IgG and -IgA
detection, included 32 serum samples drawn from inhabitants of
Fortaleza: 22 from normal individuals and 10 from hospitalized patients
with lupus eritematosous (n = 2), multiple mieloma (n = 1), autoimmune
hepatitis (n = 1), acute glomerulonephritis (n = 1), bacterial meningitidis
(n = 1), leishmaniasis (n = 2), or tetanus (n = 2). Previously, at admission,
a blood sample had been drawn from all thirty-five leptospirosis patients
for slide macroagglutination test (SAT, Bio-Manguinhos, FIOCRUZ,
RJ, Brazil). Microagglutination test (MAT) was performed on the 1st
sample of all patients with leptospirosis and in the second sample of
thirty-two using the following serovars: icterohaemorrhagiae,
copenhageni, javanica, canicola, castellonis, pyrogenes, cynopteri,
autumnalis, shermani, djasiman, australis, pomona, grippotyphosa,
wolffi, andamana, tarassovi, panama, butembo, brasiliensis, and hardjo.
MAT was considered positive for titers 1:100. The identification of the
different classes of specific immmunoglobulins was carried out by ELISA
method19. The cut-off for each immunoglobulin class was determined
by the results of the above described control group and the titers were
considered positive when > 1:400 for IgM, > 1:400 for IgG and > 1:40
for IgA. The antigen used in ELISA method was obtained from a mixture
of the following serovars: brasiliensis, canicola, cynopteri, hebdomadis
and icterohaemorrhagiae19. For determination of IgG avidity, the same
ELISA method for IgG was repeated twice in the 1st samples of group 1
patients: once washing the wells with buffered 0.85% saline containing
0.05% Tween and 6M urea after the wells had been coated with the
antigen preparation and incubated with the samples, and once using all
of these procedures except for the addition of urea to the washing
solution4. The rational for urea treatment is that urea solution breaks the
linkage of the antigen with the low-avidity antibody but not the linkage
of the antigen with the high-avidity antibody. The ratio, at 1:400 dilution,
of the optical density (OD) with (U+) to the OD without (U-) urea was
calculated and expressed as a percentage: [U+/U-] x100. SAT was carried
out at the Laboratório Central de Saúde Pública, Fortaleza, CE and MAT
at the Centro de Controle de Zoonoses, São Paulo, SP. The identification
of IgM, IgG and IgA specific antibodies and the IgG avidity determination
were both carried out at the Serology Section, Instituto Adolfo Lutz,
São Paulo, SP.
Ethics and statistical analysis: The study was approved by the Ethics
Committees of both Hospital das Clínicas in São Paulo, SP and Hospital
Universitário Walter Cantídio in Fortaleza, CE. All enrolled individuals,
i. e., patients with leptospirosis, normal individuals and non leptospirosis
patients whose blood samples were used as control group gave their
written informed consent. For statistical comparison of the
immunoglobulin titers in the 2 groups, the antilog2 of each titer was
used: e.g. a titer = 1:12,800 was considered in the statistical analysis as
= 7 (2-7 = 1/128). Statistical analysis of quantitative variables consisted
of bivariate analysis with Student’s “t“ test for variables with normal
distribution or Mann-Whitney´s test for those with no normal distribution.
Gaussian distribution was tested using the Kolmogorov-Smirnov test.
Fischer’s exact test or Chi-square test were used for comparisons of
proportions or qualitative variables (GraphPad Prism software, version
2.01, 1996). The data are presented as mean ± SD or percentage. The
adopted significance level was p  0.05.
RESULTS
All but five patients were from Fortaleza, four of these five non-
dwellers were from group 1 (Fischer’s test, p = 0.05). Thirty patients
were men (86%), aged 18 to 55 years (34 ± 10 years), and five were
women, aged 32 to 48 years (38 ± 6 years). There was no significant
difference in age between men and women. All of the women resided in
Fortaleza. In group 1, all patients were men and in group 2, there were
seventeen men and five women (Fischer’s test, p = 0.08). In group 1, the
age was 40 ± 10 years and in group 2, it was 33 ± 10 years (p = 0.06).
SAT was positive in 83% of the thirty five patients: thirteen from group
1 (100%) and fifteen from group 2 (68%, Fischer’s test, p = 0.07). MAT
was performed in the first sample of all patients and in the second sample
of 32 patients: 22 of group 2 and 10 of group 1. The serovar with the
highest frequence of positivity was copenhageni. Serovar copenhageni
presented the highest in 7 patients of group 1 and in 14 of group 2.
Serovar cynopteri presented the highest titer in 4 patients of group 1 and
3 of group 2, both serovars copenhageni and icterohaemorrhagiae had
the same highest titer in 3 patients of group 1 and 2 of group 2. Serovar
icterohaemorrhagiae had the highest titer in one patient of group 1 and
in 2 of group 2. One of each serovar grippotyphosa, javanica or
andamana presented the highest titer in 3 patients of group 2. All but
four patients were also positive for serovar icterohaemorrhagiae in at
least one of the two samples. No difference in the distribution of serovars
with the highest titer was found between the 2 groups (chi-square, p =
0.19). The time from the onset of symptoms to the 1st sample collection
was similar in both groups: 14 ± 4 days in group 1 and 15 ± 2 days in
group 2 (Mann-Whitney’s test, p = 0.86); the same occurred with all the
other samples. The evolution of IgM, IgG and IgA titers in groups 1 and
2 is presented in Figure 1. As it can be observed, IgM titers throughout
the study did not differ in the 2 groups, but IgG titers remained higher in
group 1 until the 9th month. Also, IgA titers were higher in group 1 during
the 1st month. The ratio U+/U- in the 1st sample of group 1 patients was
98 ± 14% (64 to 115%). In Figure 2 it is shown the IgG individual
values of each sample without and with urea addition. There was no
difference between the groups in the percentage of penicillin treated
patients: 54% in group 1 and 50% in group 2 (p = 1.00), nor in the
percentage of patients requiring dialysis: 54% in group 1 and 45% in
group 2 (p = 0.73), nor was there a significant difference in the number
of oliguric patients: 23% in group 1 and 5% in group 2, p = 0.13 (Fischer’s
test was used for all comparisons). Group 1 remained feverish for a
longer period (5 ± 5 versus 2 ± 1 days, Mann-Whitney’s test, p = 0.03)
but other recovery parameters were similar in both groups (Data not
shown). Physical examination at admission showed differences (Fischer’s
test) between the 2 groups only regarding the presence of dehydration
(100% in group 1 and 41% in group 2, p < 0.001) and dyspnea (69% in
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Table 1
Maximum values of laboratory parameters in groups 1 and 2 during
hospitalization
Group 1 n = 13 Group 2 n = 22
Leukocytes (x103/mm3) 13.2 ± 3.7 12.4 ± 6.0
Bilirubin (mg/dL) 25 ± 11 21 ± 13
GOT (IU/L) 141 ± 113 100 ± 63
GPT (IU/L) 81 ± 42 72 ± 49
LDH (IU/L) c 607 ± 217 762 ± 439
CK (IU/L) b 274 ± 103 1403 ± 927
P
creat 
(mg/dL) 6.9 ± 2.5 5.0 ± 2.6a
U
prot
V (mg/24 hours) 736 ± 125 673 ± 119
Data are presented as mean ± 1SD; GOT: Glutamic oxalacetic transaminase;
GPT:Glutamic piruvic transaminase; LDH: Lactic dehydrogenase; CK:
Creatinekinase; P
creat 
: Plasma creatinine; U
prot
V: Proteinuria; a p = 0.04 versus
group 1; b In group 1 n = 11, in group 2 n = 20; c In group 2 n = 21
Table 2
Minimum values of electrolytes, hemoglobin, platelets, albumin and arterial
blood oxigenation in groups 1 and 2 during hospitalization
Group 1 n = 13 Group 2 n = 22
Hemoglobin (g/dL) 10.8 ± 1.4 10.8 ± 1.6
Platelets (x 103/mm3) 58 ± 42 67 ± 51
Albumin (g/dL) c 2.6 ± 0.6 3.0 ± 0.8
PaO
2
 (mm Hg) d 85 ± 13 96 ± 14a
Bicarbonate (mEq/L) 20 ± 3 21 ± 5
P
Na
 (mEq/L) 128 ± 4 131 ± 5b
P
K 
(mEq/L) 3.2 ± 0.5 3.2 ± 0.5
Data are presented as mean ± 1SD; PaO
2
: Arterial oxigen partial pressure while
breathing room air; P
Na
: Plasma sodium; P
K 
: Plasma potassium; a p = 0.02 versus
group 1; b p = 0.07 versus group 1; c In group 2 n = 18; d In group 1 n = 12.
Fig. 1 - Evolution of IgM, IgG and IgA titers in group 1 and group 2. Each point represents the mean of values obtained in each time. Axis y shows the reciprocal titers. Axis x shows the mean
time when the samples were collected. Group 1 is represented as fill triangles and straight lines and group 2 as fill squares and interrupted lines. * p < 0.05.
Fig. 2 - Evaluation of IgG affinity in the first sample of group 1 patients. U-: without urea
addition. U+: with urea addition. Each symbol represents one patient from group 1. Axis y
shows the reciprocal titers.
group 1 and 14% in group 2, p = 0.002). Group 1 patients had worse
renal and pulmonary function, as shown by the higher levels of plasma
creatinine, as well as by the lower levels of arterial blood oxygenation
(which is compatible with the more frequent presence of dyspnea in this
group) (Tables 1 and 2). Group 1 tended to present lower levels of plasma
sodium than group 2: 128 ± 4 versus 131 ± 5 mEq/L (Student’s “t” test,
p = 0.07) (Table 2). No statistical differences were found between the
groups in hepatic and haematologic parameters. Only one patient died.
He was from group 1 and died from adult respiratory distress syndrome
in the 12th day of hospitalization.
DISCUSSION
Group 1 patients that presented a more intense and lasting immune
response also had more severe renal and pulmonary involvement and
remained feverish for a longer period. Therefore, two questions arise: 1.
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why did group 1 patients have this intense and long lasting humoral
response? and 2. how can an intense immune response intensify the
severity of leptospirosis since it is known that IgG antibodies are
protective?
Specific humoral response in leptospira infection is characterized
by IgM antibodies detection beginning on the 3rd day of symptoms, and,
from the second week on, also by IgG antibodies detection1,19,22. IgA
specific antibodies are usually detected from the 5th day up to the 9th
month of the infection19. But not all patients produce IgG antibodies.
The early detection of specific IgM and IgG is a general indicator of
reinfection in various infectious diseases. A recent study of dengue
showed that both IgM and IgG are detected early in patients with dengue
hemorrhagic fever, but only later in patients with nonhemorrhagic
dengue3. After a primary infection, IgG antibodies initially show low-
avidity to the antigen and the antigen-antibody complex is easily
disassociated. Later, the avidity to the antigen increases and the antigen-
antibody complex becomes more stable23. In toxoplasma and rubella
reinfection, it was shown that the IgG antibodies present early high-
avidity4,13,15,17. Although this behaviour had not been described in
leptospirosis, reinfection might be suspected from the early detection of
high-avidity specific IgG antibodies concomitant with IgM antibodies
as it was found in group 1.
The humoral immune response of group 1 patients was more intense
and had a longer duration than that of group 2. The IgG and IgA titers of
group 1 were higher and were sustained for a longer period than those
of group 2. The response of IgM antibodies was not statistically different
between the two groups. The finding of high U+/U- ratio (95 ± 14%) in
the 1st sample of group 1, drawn on about the 15th day from the onset of
symptoms, might indicate the presence of high avidity antibodies, i.e., a
secondary humoral response to a reinfection (as occurs in other infectious
diseases)3,4,13,15,17. For toxoplasma and rubella, U+/U- ratio value  25%
has been adopted as indicative of high-avidity4,13,17. In addition, the finding
that on about the 15th day from the symptoms onset all patients of group
1 had positive SAT (compared to only 68% of group 2) also indicates
the presence of an immune mechanism trigger in group 1.
Group 1 patients tended to be older and all were men, both of which
reinforce the hypothesis of reinfection. It is known that the prevalence
of leptospirosis is higher among men and that the prevalence of positive
serology increases with age, probably resulting from more frequent
exposition to leptospira8,9.
Group 1 patients remained feverish for a longer period. This finding
may also indicate a more intense immune response due to previous
infection, in analogy with the experimental result that fever was induced
by virulent leptospire injection in immunized rabbits, whereas non-
immunized rabbits exhibited no fever after injection10.
In trying to answer the 2nd proposed question about intensity of
immune response and leptospirosis severity, there are some findings in
the literature to be considered. There is a report that among ten dogs
with natural acute leptospiral infection and concomitant finding of
positive IgM and IgG specific antibodies, only two of them survived12.
The finding of concomitant IgG and IgM presence in acute disease in
these dogs suggests either reinfection or a long period elapsed since
vaccination. The leptospirosis severity in those dogs could be related to
an immune response which was insufficient to protect from the present
infection, but still active enough to induce intense inflammatory response.
An intense immune response induces a very high level of
inflammatory cytokines (for instance TNF) resulting in severe tissue
lesion. TNF levels in ten patients with acute leptospirosis were
measured. Nine of them showed an increased level. The highest level
was found in the one with acute renal failure7. In another study of eighteen
patients with leptospirosis, TNF was detected in three of those four
that died (all with kidney, liver and lung involvement), whereas TNF
was detected in only one patient among the fourteen survivors21.
In a recent paper on antibody toxicity in Cryptococcus neoformans
infection, it was shown that specific IgG1 administration to infected
animals induced acute lethal toxicity. This did not happen with specific
IgM, IgG3 or IgA administration14. These data suggest that the IgG
subclass can have a role in determining protection or increasing the
severity of the disease. In the present paper, the IgG subclasses were not
identified.
It has been reported that increased titers of anticardiolipin antibodies
are present in leptospirosis patients with severe complications, but not
in those with uncomplicated leptospirosis18. This finding suggests that
even non-specific humoral immune response could be involved in the
severity of the disease.
The possibility that the presence of specific antibodies may worsen
cellular lesion is also supported by the experimental finding that the
attachment of virulent leptospires to cells is enhanced by sub-
agglutinating amounts of homologous antiserum10.
The immunity to leptospirosis depends on the immune response of
the infected individual and on the virulence of the infecting serovar.
Some individuals maintain high titers of IgG and IgM antibodies for
extended periods of time while others do not even produce IgG
antibodies2. In the present study we did not intend to isolate leptospira
thus it was not possible to identify the infectant serovar. The results of
MAT showed that both groups presented similar distribution of serovars.
Thus no conclusion about the role of the infectant serovar on the severity
of the disease could be taken from our results.
In conclusion, we propose that the severity of Weil’s disease can be
determined not only by the virulence of the infecting serovar, but also
by the intensity of immune response; the more intense and early the
immune response, the more severe the disease.
RESUMO
A gravidade da leptospirose pode estar associada à intensidade da
resposta imune humoral
A gravidade da leptospirose parece estar aumentando principalmente
quanto ao envolvimento pulmonar. Essa maior gravidade poderia ser
decorrente de uma resposta imunológica mais intensa, já que tanto a
insuficiência renal, quanto a plaquetopenia e as lesões pulmonares são
encontradas na fase imune da doença. Para investigar esta hipótese foram
detectados por ELISA anticorpos IgM, IgG e IgA específicos em amostras
de sangue de 35 pacientes internados com síndrome de Weil colhidas a
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partir de cerca de 15 dias do início dos sintomas até 1 ano após a alta. Os
pacientes foram divididos em 2 grupos conforme o seu título de IgG na
primeira amostra, colhida com até 2 semanas de sintomas: grupo 1 (n =
13) com título > 1:400 (positivo) e grupo 2 (n = 22) com título  1:400
(negativo). Os anticorpos IgG no grupo 1 na primeira amostra mostraram
alta avidez pelo antígeno o que sugere reinfecção. Mesmo em amostras
mais tardias os títulos de IgG e IgA no grupo 1 foram mais elevados que
no grupo 2. Os pacientes do grupo 1 eram mais idosos, permaneceram
com febre por mais tempo e tiveram maior comprometimento renal e
pulmonar. Estes resultados sugerem que a gravidade da leptospirose pode
estar associada à intensidade da resposta humoral.
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